Management of Acute Hepatitis

Initial Assessment and Diagnosis

• The American Association for the Study of Liver Diseases recommends obtaining comprehensive laboratory evaluation including liver enzymes, prothrombin time/INR, complete blood count, comprehensive metabolic panel, and viral hepatitis serologies in patients with suspected acute hepatitis 1
• The American Association for the Study of Liver Diseases suggests performing hepatitis serological testing to identify acute viral infection even when another etiology is suspected 2, 3
• Consider HCV RNA testing when acute hepatitis C is suspected due to exposure, clinical presentation, or elevated aminotransferase levels, as recommended by the American Association for the Study of Liver Diseases 4
• Obtain detailed medication history including all prescription and non-prescription drugs, herbs, and dietary supplements taken over the past year, as recommended by the American Association for the Study of Liver Diseases 2, 3

Etiology-Specific Management

Viral Hepatitis

• For acute viral hepatitis A and B, provide supportive care as no virus-specific treatments have proven effective, according to the American Association for the Study of Liver Diseases 2, 1
• For suspected herpes virus hepatitis, initiate acyclovir treatment immediately, as recommended by the American Association for the Study of Liver Diseases 2, 1
• For acute hepatitis C, monitor HCV RNA for at least 12-16 weeks to detect potential spontaneous clearance before starting treatment, as recommended by the American Association for the Study of Liver Diseases 4
• If treatment is indicated for acute hepatitis C, pegylated IFN-α monotherapy for 24 weeks can achieve viral eradication in >90% of patients, according to the European Association for the Study of the Liver 5

Drug-Induced Hepatotoxicity

• Discontinue all but essential medications in the setting of acute liver failure due to possible drug hepatotoxicity, as recommended by the American Association for the Study of Liver Diseases 2, 1, 3
• Determine ingredients of non-prescription medications whenever possible, according to the American Association for the Study of Liver Diseases 2, 3

Autoimmune Hepatitis

• Consider liver biopsy to establish diagnosis when autoimmune hepatitis is suspected, as recommended by the American Association for the Study of Liver Diseases 6
• Treat with corticosteroids (prednisone, 40-60 mg/day), according to the American Association for the Study of Liver Diseases 6

Mushroom Poisoning

• Administer penicillin G and silymarin (30-40 mg/kg/day for 3-4 days), as recommended by the American Association for the Study of Liver Diseases 2, 1
• List patients for transplantation, as this procedure is often the only lifesaving option, according to the American Association for the Study of Liver Diseases 2, 1

Management of Acute Liver Failure

• Transfer patients with signs of acute liver failure (coagulopathy and any degree of mental alteration) to ICU immediately, as recommended by the American Association for the Study of Liver Diseases 1
• Administer N-acetylcysteine regardless of suspected etiology, according to the American Association for the Study of Liver Diseases 1
• Contact liver transplant unit early for all patients with acute liver failure, as recommended by the American Association for the Study of Liver Diseases 1

Follow-up

• For untreated patients with chronic hepatitis C and non-sustained responders, regular follow-up is recommended, according to the European Association for the Study of the Liver 5
• Assess untreated patients every 1-2 years with a non-invasive method, as recommended by the European Association for the Study of the Liver 5
• Continue HCC screening indefinitely in patients with cirrhosis, according to the European Association for the Study of the Liver 5

Special Populations

Pregnant Patients

• For acute fatty liver of pregnancy or HELLP syndrome, consult obstetrical services and expedite delivery, as recommended by the American Association for the Study of Liver Diseases 6
• Be aware that pregnancy (especially third trimester) increases the risk of ALF due to herpes virus, according to the American Association for the Study of Liver Diseases 6

Active Substance Users

• Treatment of patients with active illicit drug abuse should be decided on an individual basis in an interdisciplinary team with addiction specialists, as recommended by the European Association for the Study of the Liver 5
• Treatment of patients on stable maintenance substitution therapy can be safely performed with only slightly reduced SVR rates compared to conventional HCV patients, according to the European Association for the Study of the Liver 5

Common Pitfalls to Avoid

• Delaying transfer to a transplant center for patients with acute liver failure, as warned by the American Association for the Study of Liver Diseases 1
• Failing to identify specific etiologies that might influence treatment, as warned by the American Association for the Study of Liver Diseases 1
• Using benzodiazepines for sedation in patients with liver failure, as warned by the American Association for the Study of Liver Diseases 1
• Administering nephrotoxic agents, as warned by the American Association for the Study of Liver Diseases 1
• Routinely correcting coagulation abnormalities without active bleeding, as warned by the American Association for the Study of Liver Diseases 1
• Delaying corticosteroid treatment in suspected autoimmune hepatitis, as warned by the American Association for the Study of Liver Diseases 1

Treatment of Acute Viral Hepatitis

General Supportive Management

• The American Association for the Study of Liver Diseases recommends avoiding all hepatotoxic medications, particularly acetaminophen, and alcohol in patients with acute viral hepatitis 7
• The American Association for the Study of Liver Diseases suggests monitoring hepatic panels (ALT, AST, bilirubin, INR) every 2-4 weeks until resolution in patients with acute viral hepatitis 7

Virus-Specific Treatment Approaches

• The American Association for the Study of Liver Diseases recommends initiating oral nucleoside analogs (entecavir or tenofovir preferred) for patients with persistent severe hepatitis or acute liver failure due to hepatitis B 8
• The American Association for the Study of Liver Diseases suggests not routinely treating uncomplicated acute hepatitis B with antivirals, as this may impair natural immunity 8
• The American Association for the Study of Liver Diseases recommends initiating direct-acting antiviral (DAA) therapy immediately upon diagnosis of acute HCV with detectable RNA 7
• The American Association for the Study of Liver Diseases suggests referring patients with injection drug use-related acute HCV to addiction medicine specialists 7
• The American Association for the Study of Liver Diseases recommends counseling patients to avoid sharing injection equipment and consider barrier precautions during sex (even in monogamous relationships during acute phase due to higher transmission risk) in patients with acute HCV 7

Critical Monitoring Parameters

• The American Association for the Study of Liver Diseases recommends assessing for signs of acute liver failure, such as coagulopathy (prolonged INR), mental status changes, and rising bilirubin, in patients with acute viral hepatitis 7

Common Pitfalls to Avoid

• The American Association for the Study of Liver Diseases recommends not using acetaminophen or alcohol during acute hepatitis 7
• The American Association for the Study of Liver Diseases suggests not routinely treating uncomplicated acute hepatitis B with antivirals, as this may impair natural immunity 8
• The American Association for the Study of Liver Diseases recommends not waiting for spontaneous clearance in acute hepatitis C - treat immediately 7

Management of Acute Viral Hepatitis

Initial Assessment and Diagnosis

• The American Association for the Study of Liver Diseases (AASLD) recommends obtaining comprehensive laboratory testing, including prothrombin time/INR, liver enzymes, complete blood count, comprehensive metabolic panel, viral hepatitis serologies, acetaminophen level, and toxicology screen, to assess for coagulopathy and potential acute liver failure 9
• The AASLD guidelines suggest that if prothrombin time is prolonged by 4-6 seconds or more (INR ≥1.5) and there is any alteration in mental status, diagnose acute liver failure and admit to ICU immediately 9

Virus-Specific Management

• The AASLD recommends initiating direct-acting antiviral (DAA) therapy immediately upon diagnosis of acute HCV with detectable RNA, as this approach has been shown to reduce HCV transmission and prevent loss to follow-up 10, 11
• The AASLD guidelines suggest that the same DAA regimens recommended for chronic HCV infection should be used for acute HCV infection 11

General Supportive Care Measures

• The AASLD recommends that all patients with acute viral hepatitis should avoid all hepatotoxic medications, particularly acetaminophen, and abstain completely from alcohol 10, 11

Monitoring and Follow-Up

• The AASLD suggests monitoring hepatic panels (ALT, AST, bilirubin, INR) every 2-4 weeks until resolution 10, 11
• The AASLD guidelines recommend watching for signs of acute liver failure, including increasing bilirubin, prolonged INR, and mental status changes 10, 11

Transmission Prevention and Counseling

• The AASLD recommends counseling acute hepatitis C patients to avoid sharing injection equipment and to consider barrier precautions during sex, even in monogamous relationships during the acute phase 10, 11
• The AASLD guidelines suggest referring patients with injection drug use history to addiction medicine specialists 10, 11, 12

When to Consider Liver Transplantation

• The AASLD recommends immediately referring to a transplant center if INR >1.5 with any signs of hepatic encephalopathy 10, 11

Critical Pitfalls to Avoid

• The AASLD guidelines suggest not delaying ICU transfer for patients with coagulopathy and mental status changes 9
• The AASLD recommends not waiting for spontaneous clearance of acute hepatitis C - instead, treat immediately 10, 11
• The AASLD guidelines suggest not using acetaminophen or alcohol during acute hepatitis 10, 11

Acute Hepatitis A Management (2026)

Diagnosis and Initial Assessment

• Confirm acute hepatitis A infection by detecting IgM anti‑HAV antibodies, because clinical features alone cannot reliably differentiate hepatitis A from other viral hepatitides. 13

Supportive Care

• Provide only supportive care; no antiviral agents have demonstrated efficacy for hepatitis A, but patients should be closely monitored for the rare development of acute liver failure. 13

Expected Clinical Course

• The majority of individuals recover completely within approximately two months; however, 10–15 % may experience a relapsing illness during the first six months after onset. 13
• Patients with pre‑existing chronic liver disease are at higher risk for progression to acute liver failure. 13

Post‑Exposure Prophylaxis for Contacts

• Administer hepatitis A immune globulin (IG) to unvaccinated contacts within 14 days of exposure; IG provides >85 % protection against infection. 13
• Target IG to household members, co‑habitants, sexual partners, and any persons with ongoing close personal contact with the index case. 13
• Do not postpone IG administration while awaiting anti‑HAV testing, as delays reduce prophylactic effectiveness and are not cost‑effective. 13
• Hepatitis A vaccine alone is not recommended for post‑exposure prophylaxis; however, individuals who receive IG and are eligible for vaccination should be offered the vaccine subsequently. 13

Acute Hepatitis A: Diagnosis, Supportive Management, and Post‑Exposure Prophylaxis

Diagnosis

• Detect IgM anti‑HAV antibodies to confirm acute hepatitis A, because clinical features alone cannot reliably distinguish it from other viral hepatitides. 14
• Serologic testing is essential for diagnosis, as hepatitis A cannot be differentiated from other hepatitis types based on presentation alone. 14

Primary (Supportive) Treatment

• Provide rest, adequate hydration, and symptomatic relief for nausea, loss of appetite, and malaise; no specific antiviral therapy has proven effective. [14][15]
• No dietary restrictions are required, although patients often experience reduced appetite during the acute phase. 15

Monitoring and Hospitalization

• Admit patients who develop dehydration from persistent vomiting or who exhibit signs of acute liver failure (e.g., coagulopathy, altered mental status). 15

Expected Clinical Course

• Approximately 10–15 % of individuals may experience a relapsing illness within the first six months after onset. 14

Post‑Exposure Prophylaxis for Contacts

• Administer hepatitis A immune globulin (IG) to unvaccinated close contacts within 14 days of exposure; IG provides >85 % protection against infection. 15
• Target IG to household members, co‑habitants, sexual partners, and any persons with ongoing close personal contact with the index case. 15

Medication Considerations

• Avoid prescribing drugs that are primarily metabolized by the liver without careful assessment, as hepatic clearance is impaired during acute infection. 15